Increased survival in advanced primary biliary cirrhosis patients with regular albumin infusions?

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 8, 1999, Pages 927-930

  Tan, Adriaan C I T L ^a   Mulder, Chris J J ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Chronic liver disease; Primary biliary cirrhosis; Serum albumin; Survival

Indexed keywords

ALBUMIN; SERUM ALBUMIN;

ADULT; ARTICLE; CASE REPORT; DRUG INFUSION; FEMALE; HUMAN; PALLIATIVE THERAPY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL;

EID: 0032796671     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908000-00021     Document Type: Article

References (19)

1. 1 Poupon RE, Poupon R, Balkau B, UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis, N Engl J Med 1994; 330:1342-1347.
2. 2 Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GBG, et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989; 320:1709-1713.
3. 3 Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988; 8:385-401.
4. 4 Emerson TE. Unique features of albumin: a brief review. Crit Care Med 1989; 17:690-694.
5. 5 Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and plygeline in cirrhotic paliems with ascites treated by paracentesis. Gastroenterohgy 1996; 111:1002-1010.
6. 6 Luca A, Garcia-Pagan JC, Bosch J, Feu F, Jimenez W, Gines A, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatology 1995; 22:753-758.
7. 7 Kneppelhout JC, Mulder CJJ, Berge-Henegouwen GP, de Vries RA, Brandt KH. Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late state disease. Neth J Med 1992; 41:11-16.
8. 8 Pasha TM, Dickson ER. Survival algorithms and outcome analysis in primary biliary cirrhosis. Semin Liver Dis 1997; 17:147-158.
9. 9 Dickson ER, Grambsch PM, Fleming TR, Fisher LC, Langworthy A. Prognosis in primary biliary cirrhosis: model of decision making. Hepatology 1989; 10:1-7.
10. 10 Murtaugh PA, Dickson ER, van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, et al. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994; 20:126-134.
11. 11 Wasil M, Halliwell B, Hutchison DC, Baum H. The antioxidant action of human extracellular fluids, Biochem J 1987; 243:219-223.
12. 12 Caraceni P, Gasbarrini A, van Thiel DH, Borle AB. Oxygen free radical formation by rat hepatocytes during postanoxic reoxygenation: scavenging effect of albumin. Am J Physiol 1994; 266:G451 -G458.
13. 13 Kaminski MV, Haase TJ. Albumin and colloid osmotic pressure. Implications for fluid resuscitation. Critical Care Clinics 1992; 8:311 -321.
14. 14 Jorgensen KA, Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res 1980; 17:13-18.
15. 15 Morley D, Santamore WP, Bove AA. Inhibition of platelet and red blood cell accumulation on damaged arterial surfaces with albumin pretreatment. Thromb Res 1989; 56:265-276.
16. 16 Chang RS, Wright K, Effros RM. Role of albumin in prevention of edema in perfused rabbit lungs. J Appl Physiol 1981; 50:1065-1070.
17. 17 Curry FE. Effect of albumin on the structure of the molecular filter at the capillary wall. Fed Proc 1985; 44:2610-2613.
18. 18 Busund R, Ronning G, Lindsetmo RO, Rasmussen-Busund LT, Mollnes TE, Konopski Z, et al. The effects of plasma and albumin infusion on organ function and sepsis markers in experimental gram-negative sepsis. Shock 1994; 2:402-407.
19. 19 Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317:235-240.